Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-006861
Filing Date
2004-03-08
Accepted
2004-03-08 10:06:25
Documents
9
Period of Report
2003-12-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2130362z10-k.htm 10-K 621746
3 EX-10.16.4 a2130362zex-10_164.txt EX-10.16.4 14814
4 EX-10.21.2 a2130362zex-10_212.txt EX-10.21.2 4387
5 EX-21 a2130362zex-21.txt EX-21 242
6 EX-23 a2130362zex-23.txt EX-23 895
7 EX-31.1 a2130362zex-31_1.txt EX-31.1 3522
8 EX-31.2 a2130362zex-31_2.txt EX-31.2 3519
9 EX-32 a2130362zex-32.txt EX-32 1554
10 EX-99 a2130362zex-99.txt EX-99 43809
  Complete submission text file 0001047469-04-006861.txt   696893
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 04653673
SIC: 2836 Biological Products, (No Diagnostic Substances)